Cargando…
Metformin and simvastatin synergistically suppress endothelin 1‐induced hypoxia and angiogenesis in multiple cancer types
Multiple cancers have been reported to be associated with angiogenesis and are sensitive to anti‐angiogenic therapies. Vascular normalization, by restoring proper tumor perfusion and oxygenation, could limit tumor cell invasiveness and improve the effectiveness of anticancer treatments. However, the...
Autores principales: | Liu, Jie, Wang, Huxia, Zhang, Miao, Li, Yazhao, Wang, Ruiqi, Chen, He, Wang, Bo, Gao, Xiaoqian, Song, Shaoran, Wang, Yaochun, Ren, Yu, Li, Juan, Liu, Peijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899631/ https://www.ncbi.nlm.nih.gov/pubmed/36156330 http://dx.doi.org/10.1111/cas.15602 |
Ejemplares similares
-
DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells
por: Song, Shaoran, et al.
Publicado: (2022) -
Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer
por: Song, Shaoran, et al.
Publicado: (2022) -
Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
por: Wang, Jichang, et al.
Publicado: (2015) -
Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion
por: Wang, Ji-Chang, et al.
Publicado: (2017) -
Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
por: Liu, Jie, et al.
Publicado: (2020)